v3.26.1
CONSOLIDATED STATEMENT OF OPERATIONS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenue $ 238,150 $ 245,913
Cost of revenue (exclusive of depreciation shown separately below) 9,693 13,015
Gross profit 228,457 232,898
Operating costs and expenses:    
Selling and marketing expense 139,933 118,541
General and administrative expense 57,931 57,319
Product development expense 10,440 27,087
Depreciation 14,694 9,948
Restructuring 14,923 0
Total operating costs and expenses 237,921 212,895
Operating (loss) income (9,464) 20,003
Interest expense (5,330) (5,044)
Other income, net 5,099 4,828
(Loss) earnings before income taxes (9,695) 19,787
Income tax benefit (provision) 717 (4,681)
Net (loss) earnings attributable to Angi Inc. shareholders $ (8,978) $ 15,106
Per share information attributable to Angi Inc. shareholders:    
Basic (loss) earnings per share (USD per share) $ (0.22) $ 0.30
Diluted (loss) earnings per share (USD per share) $ (0.22) $ 0.30
Stock-based compensation expense by function:    
Total stock-based compensation expense $ 2,752 $ (2,287)
Selling and marketing expense    
Stock-based compensation expense by function:    
Total stock-based compensation expense 275 636
General and administrative expense    
Stock-based compensation expense by function:    
Total stock-based compensation expense 2,853 (6,847)
Product development expense    
Stock-based compensation expense by function:    
Total stock-based compensation expense $ (376) $ 3,924